Upadacitinib – March 2026

Tablet 15 mg, Tablet 30 mg, Tablet 45 mg

  • Brand names:
    • Rinvoq®
  • Pharmaceutical Company:
    • ABBVIE PTY LTD
  • Condition/Indication: Fistulising Crohn’s disease (FCD)
  • Meeting Date: March 2026
Public Summary Documents
Last updated
11 March 2026